BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25968067)

  • 1. MAPK inhibitors modulate Smad2/3/4 complex cyto-nuclear translocation in myofibroblasts via Imp7/8 mediation.
    Jiang Y; Wu C; Boye A; Wu J; Wang J; Yang X; Yang Y
    Mol Cell Biochem; 2015 Aug; 406(1-2):255-62. PubMed ID: 25968067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compound Astragalus and Salvia miltiorrhiza extracts modulate MAPK-regulated TGF-β/Smad signaling in hepatocellular carcinoma by multi-target mechanism.
    Boye A; Wu C; Jiang Y; Wang J; Wu J; Yang X; Yang Y
    J Ethnopharmacol; 2015 Jul; 169():219-28. PubMed ID: 25934513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitogen-activated protein kinase inhibitors reduce the nuclear accumulation of phosphorylated Smads by inhibiting Imp 7 or Imp 8 in HepG2 cells.
    Hu X; Kan H; Boye A; Jiang Y; Wu C; Yang Y
    Oncol Lett; 2018 Apr; 15(4):4867-4872. PubMed ID: 29552126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2/3 at linker regions in vivo and in vitro.
    Wu C; Chen W; Ding H; Li D; Wen G; Zhang C; Lu W; Chen M; Yang Y
    Life Sci; 2019 Dec; 239():116881. PubMed ID: 31678285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of transforming growth factor beta(1)/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts.
    He S; Liu X; Yang Y; Huang W; Xu S; Yang S; Zhang X; Roberts MS
    Br J Dermatol; 2010 Mar; 162(3):538-46. PubMed ID: 19772524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAPK inhibitors differently modulate TGF-β/Smad signaling in HepG2 cells.
    Boye A; Kan H; Wu C; Jiang Y; Yang X; He S; Yang Y
    Tumour Biol; 2015 May; 36(5):3643-51. PubMed ID: 25560488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts.
    Furukawa F; Matsuzaki K; Mori S; Tahashi Y; Yoshida K; Sugano Y; Yamagata H; Matsushita M; Seki T; Inagaki Y; Nishizawa M; Fujisawa J; Inoue K
    Hepatology; 2003 Oct; 38(4):879-89. PubMed ID: 14512875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAPK/AP-1-dependent regulation of PAI-1 gene expression by TGF-beta in rat mesangial cells.
    Guo B; Inoki K; Isono M; Mori H; Kanasaki K; Sugimoto T; Akiba S; Sato T; Yang B; Kikkawa R; Kashiwagi A; Haneda M; Koya D
    Kidney Int; 2005 Sep; 68(3):972-84. PubMed ID: 16105028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione suppresses TGF-beta-induced PAI-1 expression by inhibiting p38 and JNK MAPK and the binding of AP-1, SP-1, and Smad to the PAI-1 promoter.
    Vayalil PK; Iles KE; Choi J; Yi AK; Postlethwait EM; Liu RM
    Am J Physiol Lung Cell Mol Physiol; 2007 Nov; 293(5):L1281-92. PubMed ID: 17890327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta1-dependent activation of Smad2/3 and up-regulation of PAI-1 expression is negatively regulated by Src in SKOV-3 human ovarian cancer cells.
    Wakahara K; Kobayashi H; Yagyu T; Matsuzaki H; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
    J Cell Biochem; 2004 Oct; 93(3):437-53. PubMed ID: 15372629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compound Astragalus and Salvia miltiorrhiza Extract exerts anti-fibrosis by mediating TGF-beta/Smad signaling in myofibroblasts.
    Yang Y; Yang S; Chen M; Zhang X; Zou Y; Zhang X
    J Ethnopharmacol; 2008 Jul; 118(2):264-70. PubMed ID: 18502066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism.
    Rodríguez-Vita J; Sánchez-López E; Esteban V; Rupérez M; Egido J; Ruiz-Ortega M
    Circulation; 2005 May; 111(19):2509-17. PubMed ID: 15883213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitor m-carboxycinnamic acid bis-hydroxamide attenuates plasminogen activator inhibitor-1 expression in human pleural mesothelial cells.
    Chung CL; Sheu JR; Chen WL; Chou YC; Hsiao CJ; Hsiao SH; Hsu MJ; Cheng YW; Hsiao G
    Am J Respir Cell Mol Biol; 2012 Apr; 46(4):437-45. PubMed ID: 22033265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
    Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
    Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of TGF-beta1/MAPK-mediated PAI-1 gene expression by the actin cytoskeleton in human mesangial cells.
    Yang C; Patel K; Harding P; Sorokin A; Glass WF
    Exp Cell Res; 2007 Apr; 313(6):1240-50. PubMed ID: 17328891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular validation of the precision-cut kidney slice (PCKS) model of renal fibrosis through assessment of TGF-β1-induced Smad and p38/ERK signaling.
    Zhang S; Liu Q; Xiao J; Lei J; Liu Y; Xu H; Hong Z
    Int Immunopharmacol; 2016 May; 34():32-36. PubMed ID: 26919280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of non-SMAD and SMAD signaling in TGF-beta1-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells.
    Samarakoon R; Higgins PJ
    Thromb Haemost; 2008 Dec; 100(6):976-83. PubMed ID: 19132220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β / Smad pathway.
    He S; Yang Y; Liu X; Huang W; Zhang X; Yang S; Zhang X
    Br J Dermatol; 2012 Mar; 166(3):564-74. PubMed ID: 21967214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor-beta/Smad in HepG2 cell.
    Liu X; Yang Y; Zhang X; Xu S; He S; Huang W; Roberts MS
    J Gastroenterol Hepatol; 2010 Feb; 25(2):420-6. PubMed ID: 19793165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorofenidone inhibits transforming growth factor-beta1-induced cardiac myofibroblast differentiation.
    Chen LX; Yang K; Sun M; Chen Q; Wang ZH; Hu GY; Tao LJ
    Pharmazie; 2012 May; 67(5):452-6. PubMed ID: 22764581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.